Irinotecan hydrochloride trihydrate is a potent topoisomerase I inhibitor and a camptothecin derivative primarily used in the treatment of metastatic colorectal cancer, often administered in combination… Read more
Irinotecan hydrochloride trihydrate is a potent topoisomerase I inhibitor and a camptothecin derivative primarily used in the treatment of metastatic colorectal cancer, often administered in combination chemotherapy regimens such as FOLFIRI. To support the rigorous demands of pharmaceutical quality control, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. These materials are essential for impurity profiling, allowing laboratories to detect and quantify degradation products and synthetic by-products. Additionally, the inclusion of stable isotope-labelled compounds supports accurate analytical testing and method validation by serving as internal standards in complex bioanalytical assays. Pharmaceutical scientists and analytical chemists utilize these high-quality compounds to ensure the safety, efficacy, and consistency of this critical cytotoxic agent throughout the development and manufacturing process.